TP53 and neoplasm: From a multiregion sequencing study, Zhang et al24 identified a universal spatial heterogeneity of TP53 mutation in NSCLC; therefore, the sites and timing of tumor acquisition may cause a marked difference in the positivity and frequency of TP53 mutation.